https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.950035/full
Frontiers | Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
Introduction: Chronic inflammation is the core mechanism of the development of COPD. Corticosteroid resistance in COPD limited its anti-inflammatory potency....